Saxenda Hair Loss: How Common, How Long It Lasts, What Helps
Hair loss is not mentioned in the Saxenda label as a side effect. What people mean by it: more hair than usual coming out. Labels call it hair loss or alopecia.
- In the label
- Not listed
- Most common in the label
- Nausea 39.3%
A quick look at Saxenda
Half of the drug is gone after 13 h. Its half-life is about 13 hours, and five half-lives (2.7 d) leave about 3%.
In the SCALE Obesity and Prediabetes, 56-week trial, results were 7.4% of body weight versus 3% with placebo.
Sources: FDA label (DailyMed).
What the Saxenda label lists instead
Hair loss is not mentioned in the Saxenda label. These are the five side effects listed most often.
| Side effect | Placebo | Saxenda Saxenda | More than placebo |
|---|---|---|---|
| Nausea | 13.8% | 39.3% | +25.5 points |
| Diarrhea | 9.9% | 20.9% | +11 points |
| Constipation | 8.5% | 19.4% | +10.9 points |
| Vomiting | 3.9% | 15.7% | +11.8 points |
| Injection Site Reaction | 10.5% | 13.9% | +3.4 points |
Source: Saxenda label (DailyMed).
Hair loss with Saxenda compared with other GLP-1s
Each label relies on separate trials that included different groups of people. Consider it a rough guide.
The pill forms are covered in that table as well: Foundayo.
| Medicine | Highest rate in the label | Dose group | Placebo | People in the trials |
|---|---|---|---|---|
 Zepbound | 5% | 5 mg | 1% | Adults with obesity or overweight (weight management) |
 Foundayo | 5% | 17.2 mg | 2% | Adults with obesity or overweight (weight management) |
 Wegovy | 3% | 2.4 mg | 1% | Adults with obesity or overweight (weight management) |
 Ozempic | Listed, no rate given | – | – | – |
 Mounjaro | Listed, no rate given | – | – | – |
 Trulicity | Listed, no rate given | – | – | – |
| Byetta | Listed, no rate given | – | – | – |
 Rybelsus | Not listed | – | – | – |
| Saxenda | Not listed | – | – | – |
 Victoza | Not listed | – | – | – |
Sources: Wegovy label (DailyMed), Zepbound label (DailyMed), Foundayo label (DailyMed).
Source: FDA label (DailyMed)